Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double‐blind clinical trial
Top Cited Papers
Open Access
- 13 October 2006
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 5 (1), 31-41
- https://doi.org/10.1111/j.1538-7836.2006.02267.x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The interactions between inflammation and coagulationBritish Journal of Haematology, 2005
- Disseminated Intravascular Coagulation in SepsisChest, 2005
- Disseminated intravascular coagulation: old disease, new hopeBMJ, 2003
- Disseminated intravascular coagulation: Current concepts of etiology, pathophysiology, diagnosis, and treatmentHematology/Oncology Clinics of North America, 2003
- Disseminated Intravascular CoagulationNew England Journal of Medicine, 1999
- Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremiaAmerican Journal Of Medicine, 1989
- Beneficial effect of heparin in the management of patients with APLBritish Journal of Haematology, 1988
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.JCI Insight, 1987
- Heparin therapy in bacterial septicemiaThe Journal of Pediatrics, 1977
- Disseminated Intravascular Coagulation: Evaluation of Therapeutic ApproachesSeminars in Thrombosis and Hemostasis, 1977